Evidence map›Paper›PMID 33470041›Full record

ArticleJournal of thrombosis and haemostasis : JTH2020

Yersinia pestis escapes entrapment in thrombi by targeting platelet function.

Samantha G Palace, Olga Vitseva, Megan K Proulx, Jane E Freedman, Jon D Goguen, Milka Koupenova

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Effect of antiplatelet agents onFrontiers in microbiology · 2022
    Review
  9. Review
  10. Platelets-Disarmed guardians in the fight against the plague.Journal of thrombosis and haemostasis : JTH · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samantha G PalaceDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0002-7849-8078
Olga VitsevaDepartment of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Megan K ProulxDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0002-9524-8302
Jane E FreedmanDepartment of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Jon D GoguenDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA.
Milka KoupenovaDepartment of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0001-5934-8990
University of Massachusetts Chan Medical School · US

Funding

Racial and Ethnic Diversity in Human Extracellular RNAU01HL126495 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FREEDMAN, JANE E, GERSTEIN, MARK BENDER · 2014 to 2018
$3.4M
Extracellular RNAs: Biomarkers for Cardiovascular Risk and DiseaseUH3TR000921 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FREEDMAN, JANE E · 2015 to 2017
$3.1M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
Mechanisms of platelet reprogramming during influenza infectionR01HL153235 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOUPENOVA, MILKA · 2020 to 2024
$2.1M
Long Non-coding RNA as Mediators of Metabolic DiseaseR01HL145721 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FREEDMAN, JANE E · 2019 to 2022
$1.7M
Scanning Electron Microscope for Core EM FacilityS10RR021043 · NCRR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CRAIG, ROGER W · 2007 to 2007
$498k
UltramicrotomeS10OD021580 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HENDRICKS, GREGORY · 2016 to 2016
$53k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
American Heart Association 16SDG30450001NCATS NIH HHS UH3 TR000921NCRR NIH HHS S10 RR021043NHLBI NIH HHS HL153235NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL145721NHLBI NIH HHS R01 HL153235NHLBI NIH HHS U01 HL126495NIAID NIH HHS T32 AI095213NIH HHS N01-HC 25195NIH HHS S10 OD021580NIH HHS U01HL126495NIH HHS UH3TR000921-04
6 · The paper itself

Abstract

backgroundPlatelets are classically recognized for their role in hemostasis and thrombosis. Recent work has demonstrated that platelets can also execute a variety of immune functions. The dual prothrombotic and immunological roles of platelets suggest that they may pose a barrier to the replication or dissemination of extracellular bacteria. However, some bloodborne pathogens, such as the plague bacterium Yersinia pestis, routinely achieve high vascular titers that are necessary for pathogen transmission.

objectivesIt is not currently known how or if pathogens circumvent platelet barriers to bacterial dissemination and replication. We sought to determine whether extracellular bloodborne bacterial pathogens actively interfere with platelet function, using Y  pestis as a model system.

methodsThe interactions and morphological changes of human platelets with various genetically modified Y pestis strains were examined using aggregation assays, immunofluorescence, and scanning electron microscopy.

resultsYersinia pestis directly destabilized platelet thrombi, preventing bacterial entrapment in fibrin/platelet clots. This activity was dependent on two well-characterized bacterial virulence factors: the Y pestis plasminogen activator Pla, which stimulates host-mediated fibrinolysis, and the bacterial type III secretion system (T3SS), which delivers bacterial proteins into the cytoplasm of targeted host cells to reduce or prevent effective immunological responses. Platelets intoxicated by the Y pestis T3SS were unable to respond to prothrombotic stimuli, and T3SS expression decreased the formation of neutrophil extracellular traps in platelet thrombi.

conclusionsThese findings are the first demonstration of a bacterial pathogen using its T3SS and an endogenous protease to manipulate platelet function and to escape entrapment in platelet thrombi.

Indexed as

PlagueThrombosisYersinia pestisAnimalsBacterial ProteinsDisease Models, AnimalHemostasisHumansBacterial Proteinsblood plateletsextracellular trapsplaguethrombosisYersinia pestis

Identifiers

PMID33470041
PMCPMC8040536
OpenAlexW3081517016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.